SMC approves lenvatinib plus everolimus combination for second-line treatment of advanced kidney cancer
We are delighted to announce that the Scottish Medicines Consortium (SMC), [...]
We are delighted to announce that the Scottish Medicines Consortium (SMC), [...]
Interim results from an ongoing clinical trial of lenvatinib and [...]
The following video interview with Dr Eric Jonasch, from the [...]
The results from the renal cell carcinoma (RCC) group of [...]
In his keynote lecture at the American Society for Clinical Oncology Genitourinary [...]
The US Food and Drug Administration (FDA) have granted Breakthrough [...]
There are now a number of licensed drug options available [...]
Fantastic news for people with advanced kidney cancer: the lenvatinib [...]
This article, published in UroToday this week, is a nice summary [...]
The International Kidney Cancer Coalition (IKCC) had a booth at [...]